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Process for the preparation of 2-[[4-[(7-Chloro-4-quinolyl)amino] 
pentyl]ethylamino]ethanol sulphate 
 
A process for the preparation of 2-[[4-[(7-Chloro-4-quinolyl)amino]pentyl] 
ethylamino]ethanol sulfate of compound of Formula-I, which is represented by the following 
structural formula. 
Formula-I 
Hydroxychloroquine is chemically known as 2-[[4-[(7-Chloro-4-uinolyl) 
amino]pentyl]ethylamino]ethanol and it was disclosed in US2546658.  
US2546658 discloses process for the preparation of hydroxychloroquine, which 
involves reacting 4,7-dichloroquinoline with N'-Ethyl-N'-β-hydroxyethyl-l,4-pentadiamine in 
the presence of potassium iodide (KI) and phenol.  
The present disclosure provides an improved process for the preparation of 
Hydroxychloroquine, Hydroxychloroquine sulphate and its crystalline forms. The said 





































The compound of Formula-2 and Formula-3 used in the present invention are 
prepared by any of the processes known in prior art. 
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The following examples specifies the conditions of the process for the preparation of 
Hydroxychloroquine sulphate.  
Example-1: Preparation of Hydroxychloroquine hydrate 
 Calcium oxide (14.15 g), Potassium iodide (4 g), Tetrabutylammonium bromide (10 
g) and 2-((4-aminopentyl)(ethyl)amino)ethanol (114.4 g) were added to the mixture of 4,7-
dichloro quinolone (100 g) in n-Butanol (200 ml) at 25-30°C and stirred for 15 minutes. 
Heated the mixture to 125-130°C and stirred for 70 hrs. Cooled the mixture to 80-85°C and 
distilled-out the n-butanol at the same temperature. Cooled the mixture to 50-55°C and water 
(200 ml) was added. Mixture further cooled to 25-30°C and adjusted the mixture pH between 
5.0 – 6.0 by using hydrochloric acid. Cooled the mixture to 10-15°C and stirred for 60 
minutes. Filtered the precipitated solid and washed with water (100 ml). Dichloromethane 
(800 ml) was added to the obtained filtrate at 25-30°C. Adjusted the mixture pH between 8.4 
– 9.0 by using sodium hydroxide solution and stirred for 20 minutes at 25-30°C. Separated 
the organic layer from aqueous layer. Distilled-out the organic layer to get residue. Residue 
co-distilled in acetone (50 ml) and cooled to 25-30°C. Seeding material of 
Hydroxychloroquine hydrate (500 mg) was added to the residue at 25-30°C and stirred for 10 
minutes. Water (800 ml) was added to the residue and stirred for 10 hrs. Filtered the 
precipitated solid and washed with water. 
Yield: 190 g 
The PXRD pattern of the obtained compound is as illustrated in figure-1 
 
Example-2: Preparation of Hydroxychloroquine 
 Calcium oxide (14.15 g), Potassium iodide (4 g), Tetrabutylammonium bromide (10 
g) and 2-((4-aminopentyl)(ethyl)amino)ethanol (114.4 g) were added to the mixture of 4,7-
dichloro quinolone (100 g) in n-Butanol (200 ml) at 25-30°C and stirred for 15 minutes. 
Heated the mixture to 125-130°C and stirred for 70 hrs. Cooled the mixture to 80-85°C and 
distilled-out the n-butanol at the same temperature. Cooled the mixture to 50-55°C and water 
(200 ml) was added. Mixture further cooled to 25-30°C and adjusted the mixture pH between 
5.0 – 6.0 by using hydrochloric acid. Cooled the mixture to 10-15°C and stirred for 60 
minutes. Filtered the precipitated solid and washed with water (100 ml). Dichloromethane 
(800 ml) was added to the obtained filtrate at 25-30°C. Adjusted the mixture pH between 8.4 
– 9.0 by using sodium hydroxide solution and stirred for 20 minutes at 25-30°C. Separated 
the organic layer from aqueous layer. Distilled-out the organic layer to get residue. Residue 
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co-distilled in acetone (50 ml) and cooled to 25-30°C. Seeding material of 
Hydroxychloroquine hydrate (500 mg) was added to the residue at 25-30°C and stirred for 10 
minutes. Water (800 ml) was added to the residue and stirred for 10 hrs. Filtered the 
precipitated solid and washed with water. Dichloromethane (1000 ml) was added to the 
obtained solid at 25-30°C and stirred for 30 minutes. Separate the organic layer and distilled-
out the same. Acetone (450 ml) was added to the obtained residue. Heated the mixture to 50-
55°C and stirred for 15 minutes. Treated the mixture with carbon. Mixture cooled to 25-30°C. 
Seeding material of hydroxychloroquine (500 mg) was added to the mixture at 25-30°C and 
stirred for 3 hrs. Mixture cooled to 5-10°C and stirred for 2 hrs. Filtered the precipitated solid 
and washed with acetone. Dried to obtain title compound. 
Yield: 94 g  
M.R: 92.5-93°C; HPLC purity: 99.82% 
The PXRD pattern of the obtained compound is as illustrated in figure-2 
Example-3: Preparation of Hydroxychloroquine sulphate 
Ethanol (700 ml) was added to the hydroxychloroquine (100 g) at 25-30°C and stirred 
for 10 minutes. Heated the mixture to 45-48°C. Sulphuric acid solution (15.46 ml) was added 
to the mixture at 45-48°C and stirred for 6 hrs. Cooled the mixture to 25-30°C and stirred for 
3 hrs. Filtered the precipitated solid and washed with ethanol. Dried to obtain title compound. 
Yield: 110 g  
M.R: ~240°C 
The PXRD pattern of the obtained compound is as illustrated in figure-3 
 
The following drawings shows the PXRD pattern of above examples: 
Figure-1 
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